Skip to main content

cbdMD, Inc.

corporate_fare Company Profile

cbdMD, Inc.

YCBD·NASDAQ·Industrial Applications And Services·CIK 0001644903

cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds. The majority of its products are anchored by hemp-derived cannabinoids, including broad-spectrum and full-spectrum CBD formulations, hemp-derived Delta-9 THC products (where permitted by law), and functional products designed to address wellness needs such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. The company combines scientific rigor with high manufacturing standards to produce consistent, safe, and reliable products. cbdMD operates a multi-brand portfolio anchored by its flagship cbdMD® line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Paw CBD® is its dedicated pet-wellness brand, providing tinctures, chews, and topicals for dogs and cats. The ATRX® platform offers non-cannabinoid functional ingredients such as functional mushrooms and supports expansion into performance-driven nutraceutical and nootropic categories using synergistic ingredient combinations. Herbal Oasis ("Oasis") is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage. Products are sold through a diversified distribution network including direct-to-consumer e-commerce platforms, online marketplaces, wholesale distribution to national and regional retailers, specialty health and pet channels, and emerging international markets. This multi-channel strategy is intended to reach a broad consumer base, reduce reliance on any single distribution partner, and quickly introduce new products reflecting scientific findings, consumer trends, and regulatory dynamics. During 2025, management focused on delivering positive earnings through optimizing the product portfolio, rationalizing cost structure, and growing revenue, and on simplifying the capital structure.

cbdMD, Inc. (NASDAQ:YCBD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for YCBD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 8/10. Recent SEC coverage for YCBD spans 8-K.

Recent high-impact activity:

  • cbdMD Closes Twinlab Asset Acquisition; Pays 2.23M Shares Plus $1.75M Secured Note

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$19.19M
Net Income
-$2.04M
Diluted EPS
-$1.09
Op. Cash Flow
-$1.45M
Free Cash Flow
-$1.64M
Gross Profit
$11.97M
Operating Income
-$2.16M
Cash & Equivalents
$2.26M
Debt / Equity
0.00×
Net Margin
-10.6%
Shares Outstanding
8.92M sh
Source: 10-K · filed 2026-01-20 · accession 0001437749-26-001542

Short Interest & Short Volume

7.40 days to cover

FINRA reported short interest of 482,585 shares in YCBD as of the October 30, 2026 settlement, a 11.6% decrease from the prior period — about 7.4 days to cover at its recent average daily volume. On November 20, 2026, 28.7% of YCBD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)482,585 shares as of October 30, 2026
Change vs prior period▼ 11.6%
Days to cover7.40 at avg daily volume of 65,254
Daily short volume (FINRA facilities)28.7% of 71,677 shares on November 20, 2026
5-day average short volume32.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.3406 -5.39% today
52-week range · as of 2026-11-04 $0.33 – $2.56
Market cap
$4.03M
Volume
122K (0.8× avg)
3-mo avg 155.5K
Live data · 2026-11-21 18:39 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed YCBD - Latest Insights

YCBD
Nov 04, 2026, 5:28 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.406
Real-time Price: $0.3406 info
Change: -$0.0654 (-16%) info
Market Cap: $4.034M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets